COF vs RCUS · P/E 62, rev $53.43B vs rev $258.0M
Capital One Financial Corporation (COF) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the COF and RCUS stock pages for the full models.
Not investment advice.